PMC:7455781 / 11294-11729
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T71 | 22-24 | Disease | denotes | BH | http://purl.obolibrary.org/obo/MONDO_0010873 |
| T72 | 241-244 | Disease | denotes | MCM | http://purl.obolibrary.org/obo/MONDO_0011240 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T11 | 338-341 | Chemical | denotes | EMS | http://purl.obolibrary.org/obo/CHEBI_23994 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T76 | 0-21 | Sentence | denotes | Conflict of interests |
| T77 | 22-240 | Sentence | denotes | BH received travel grants from Novo Nordisk and Aché Pharmaceuticals; received honoraria for lectures from Novo Nordisk, Eli Lilly, and Boehringer-Ingelheim; and is on the Advisory Board for Novo Nordisk and Eli Lilly. |
| T78 | 241-435 | Sentence | denotes | MCM received travel grants from Novo Nordisk; received honoraria for lectures from Novo Nordisk, EMS Pharmaceutical, and Eurofarma Pharmaceuticals; and is on the Advisory Board for Novo Nordisk. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 239 | 70-74 | Disease | denotes | Aché | MESH:D063806 |